TipRanks
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
FDMT
4D Molecular Therapeutics
RESEARCH TOOLSreports
Want to see FDMT full AI Analyst Report?

4D Molecular Therapeutics (FDMT) Stock News & Sentiment

527 Followers
Analyst Reiterates Buy on 4D Molecular Therapeutics, Maintains $36 Price Target as 4D-150 Advances Through Late-Stage Trials
Premium
Ratings
Analyst Reiterates Buy on 4D Molecular Therapeutics, Maintains $36 Price Target as 4D-150 Advances Through Late-Stage Trials
1M ago
FDMT
4D Molecular Therapeutics Posts Strong 4D-150 Trial Results
Premium
Company Announcements
4D Molecular Therapeutics Posts Strong 4D-150 Trial Results
2M ago
8K
FDMT
4D-150’s Durable Efficacy and Clean Safety Profile Support Buy Rating and Unchanged $36 Price Target
Premium
Ratings
4D-150’s Durable Efficacy and Clean Safety Profile Support Buy Rating and Unchanged $36 Price Target
2M ago
FDMT
4D Molecular Therapeutics Buy Rating Reaffirmed on 4D-150 Pivotal Trial Momentum; Price Target Maintained at $36
Premium
Ratings
4D Molecular Therapeutics Buy Rating Reaffirmed on 4D-150 Pivotal Trial Momentum; Price Target Maintained at $36
3M ago
FDMT
4D Molecular Therapeutics Secures $200 Million Loan Facility
Premium
Company Announcements
4D Molecular Therapeutics Secures $200 Million Loan Facility
3M ago
8K
FDMT
4D Molecular Therapeutics Stockholders Back Directors and Governance
Premium
Company Announcements
4D Molecular Therapeutics Stockholders Back Directors and Governance
3M ago
8K
FDMT
Analyst Reiterates Buy on 4D Molecular Therapeutics as Wet AMD Gene Therapy Advances, Keeps $36 Price Target Unchanged
Premium
Ratings
Analyst Reiterates Buy on 4D Molecular Therapeutics as Wet AMD Gene Therapy Advances, Keeps $36 Price Target Unchanged
4M ago
FDMT
More FDMT News >

FDMT News on the Web

Insider David Kirn Sells 58,333 Shares of 4D Molecular Therapeutics Inc (FDMT)
GuruFocus News
Neutral
4D Molecular Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Alto Neuroscience, Inc. (ANRO) and Irhythm Technologies (IRTC)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Dogwood Therapeutics (DWTX), Talphera (TLPH) and 4D Molecular Therapeutics (FDMT)
TipRanks News
Neutral
4D Molecular Therapeutics (FDMT) Insider David Kirn Sells 12,415 Shares
GuruFocus News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tempus AI, Inc. Class A (TEM) and 4D Molecular Therapeutics (FDMT)
TipRanks News
Bullish
Analysts Conflicted on These Healthcare Names: Tempus AI, Inc. Class A (TEM) and 4D Molecular Therapeutics (FDMT)
TipRanks News
Bullish

News Score - Last 7 Days

Positive
FDMT
Sector Average
Media Buzz
This Week4 articles
Weekly Average0.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FDMT’s Media Buzz Sentiment?
4 articles about FDMT were published this week. In an average week, 0.5 articles are published.
    What is FDMT’s weekly average amount of articles?
    In an average week, 0.5 articles about FDMT are published.
      What is FDMT’s News Sentiment?
      100% of articles about FDMT were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CRLCharles River Labs
        DFTXDefinium Therapeutics
        AMRXAmneal Pharmaceuticals
        SMMTSummit Therapeutics
        ABEOAbeona Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week